A Decision Support Tool for Allogeneic Hematopoietic Stem Cell Transplantation for Children With Sickle Cell Disease: Acceptability and Usability Study
BackgroundIndividuals living with sickle cell disease (SCD) may benefit from a variety of disease-modifying therapies, including hydroxyurea, voxelotor, crizanlizumab, L-glutamine, and chronic blood transfusions. However, allogeneic hematopoietic stem cell transplantation (HC...
Main Authors: | Anirudh Veludhandi, Diana Ross, Cynthia B Sinha, Courtney McCracken, Nitya Bakshi, Lakshmanan Krishnamurti |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2021-10-01
|
Series: | JMIR Formative Research |
Online Access: | https://formative.jmir.org/2021/10/e30093 |
Similar Items
-
Hematopoietic Cell Transplantation for Sickle Cell Disease
by: Lakshmanan Krishnamurti
Published: (2021-01-01) -
From trust to skepticism: An in-depth analysis across age groups of adults with sickle cell disease on their perspectives regarding hydroxyurea.
by: Cynthia B Sinha, et al.
Published: (2018-01-01) -
Proponent or collaborative: Physician perspectives and approaches to disease modifying therapies in sickle cell disease.
by: Nitya Bakshi, et al.
Published: (2017-01-01) -
A pilot study of the acceptability, feasibility and safety of yoga for chronic pain in sickle cell disease
by: Nitya Bakshi, et al.
Published: (2021-06-01) -
Patient and family experience with chronic transfusion therapy for sickle cell disease: A qualitative study
by: Lauren M. Hawkins, et al.
Published: (2020-04-01)